Condition
Extrahepatic Cholangiocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Extrahepatic Cholangiocarcinoma clinical trials that are recruiting, at sites in 6 countries (most in China (3), Netherlands (1), Japan (1)). 1 was first registered in the last 30 days. By phase: Phase 2/3 (1), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1New in 30 days
- 6Countries
Newest Extrahepatic Cholangiocarcinoma clinical trials
All recruiting trials (7)
-
PDT plus radioactive biliary stent for unresectable extrahepatic cholangiocarcinoma
This study tests whether combining photodynamic therapy with a self-expandable radioactive stent can help patients with unresectable extrahepatic cholangiocarcinoma stay cancer-free longer and keep their bile ducts open.
-
Dual-target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
This trial tests a ready-to-use CAR-NK cell therapy that targets HER2 and CEACAM5 in adults with unresectable or metastatic biliary tract cancers after standard therapy to see if it can help control the disease.
-
Repeated endobiliary radiofrequency ablation with durvalumab, gemcitabine, and cisplatin for unresectable extrahepatic bile duct cancer
This trial tests whether adding repeated endobiliary radiofrequency ablation to standard durvalumab plus gemcitabine and cisplatin helps people with unresectable extrahepatic bile duct cancer live longer.
-
Blood test using cfDNA methylation to screen for biliary tract cancers
This study tests whether a blood test that reads cfDNA methylation can detect biliary tract cancers early in adults with or suspected of having these cancers.
-
Neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab vs upfront surgery for cancers of the bile ducts
This trial tests whether giving chemotherapy with pembrolizumab before surgery helps people with resectable or borderline resectable extrahepatic cholangiocarcinoma see if they have better outcomes than going straight to surgery.
-
Combining Durvalumab with Radiofrequency Ablation for Treating Extrahepatic Cholangiocarcinoma
This study is testing if combining a new immunotherapy with radiofrequency ablation and chemotherapy can help people with a type of bile duct cancer that can't be surgically removed.
-
Combining local therapy with ongoing systemic treatment for certain cancers
This study is testing whether adding local treatments to ongoing systemic therapy can help people with certain cancers keep their disease under control for longer.
Related topics
Quick answers
How many Extrahepatic Cholangiocarcinoma clinical trials are recruiting right now?
7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (3 trials), Netherlands (1 trial), Japan (1 trial), South Korea (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.